These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10800 related items for PubMed ID: 12567857

  • 1. [Studies on antitumor activity of rhEndostatin].
    Li HY, Li Y, Liu ZH, Wu HJ, Chen FH, Chen XG.
    Yao Xue Xue Bao; 2002 Oct; 37(10):763-6. PubMed ID: 12567857
    [Abstract] [Full Text] [Related]

  • 2. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM, Hanson AD, Volker KM, Vu HA, Sim BK, Fogler WE, Fortier AH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4619-26. PubMed ID: 14555538
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic efficacy of recombinant human endostatin combined with chemotherapeutics in mice-transplanted tumors.
    Zhu LP, Xing J, Wang QX, Kou L, Li C, Hu B, Wu ZW, Wang JJ, Xu GX.
    Eur J Pharmacol; 2009 Sep 01; 617(1-3):23-7. PubMed ID: 19615993
    [Abstract] [Full Text] [Related]

  • 4. Antitumor interaction of short-course endostatin and ionizing radiation.
    Hanna NN, Seetharam S, Mauceri HJ, Beckett MA, Jaskowiak NT, Salloum RM, Hari D, Dhanabal M, Ramchandran R, Kalluri R, Sukhatme VP, Kufe DW, Weichselbaum RR.
    Cancer J; 2000 Sep 01; 6(5):287-93. PubMed ID: 11079167
    [Abstract] [Full Text] [Related]

  • 5. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
    Ruggeri B, Singh J, Gingrich D, Angeles T, Albom M, Yang S, Chang H, Robinson C, Hunter K, Dobrzanski P, Jones-Bolin S, Pritchard S, Aimone L, Klein-Szanto A, Herbert JM, Bono F, Schaeffer P, Casellas P, Bourie B, Pili R, Isaacs J, Ator M, Hudkins R, Vaught J, Mallamo J, Dionne C.
    Cancer Res; 2003 Sep 15; 63(18):5978-91. PubMed ID: 14522925
    [Abstract] [Full Text] [Related]

  • 6. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 7. The anti-angiogenic activity of human endostatin inhibits bladder cancer growth and its mechanism.
    Du Z, Hou S.
    J Urol; 2003 Nov 20; 170(5):2000-3. PubMed ID: 14532841
    [Abstract] [Full Text] [Related]

  • 8. [Inhibition of tumor growth and metastasis via local administration of recombinant human endostatin adenovirus].
    Wu Y, Yang L, Zhao X, Su JM, Hu B, Liu JY, Niu T, Luo Y, Li Q, Wei YQ.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec 20; 21(6):557-61. PubMed ID: 15583981
    [Abstract] [Full Text] [Related]

  • 9. [Tea polyphenol inhibit on growth of human nasopharyngeal carcinoma cell and xenograft in nude mice].
    Feng GK, Xie BF, Liu ZC, Zhu XF, Ye YL.
    Ai Zheng; 2002 Apr 20; 21(4):392-4. PubMed ID: 12452018
    [Abstract] [Full Text] [Related]

  • 10. A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo.
    Xu YF, Zhu LP, Hu B, Rong ZG, Zhu HW, Xu JM, Wu ZW, Wang JJ, Xu GX.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):1-6. PubMed ID: 17346697
    [Abstract] [Full Text] [Related]

  • 11. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
    Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.
    Life Sci; 2006 Nov 17; 79(25):2370-81. PubMed ID: 16959272
    [Abstract] [Full Text] [Related]

  • 12. Prolactin antagonist-endostatin fusion protein as a targeted dual-functional therapeutic agent for breast cancer.
    Beck MT, Chen NY, Franek KJ, Chen WY.
    Cancer Res; 2003 Jul 01; 63(13):3598-604. PubMed ID: 12839947
    [Abstract] [Full Text] [Related]

  • 13. [Inhibition of mixture of lucid garoderma and lucid garoderma spore on tumor cell in vitro and in vivo].
    Chen LJ, Han JX, Yang WY, Lu LJ, Zhang JL, Yang QL, Yuan ST, Ding J.
    Ai Zheng; 2002 Dec 01; 21(12):1341-4. PubMed ID: 12520744
    [Abstract] [Full Text] [Related]

  • 14. [Effect of transfection of hEndostatin gene on CNE2 cell xenograft growth in nude mice].
    Yue T, Zhang P, Liu P, Deng QL, Ji QM, Li XY, Zhu ZY.
    Ai Zheng; 2003 Feb 01; 22(2):148-51. PubMed ID: 12600288
    [Abstract] [Full Text] [Related]

  • 15. Effects of retinoic acid on metastasis and its related proteins in gastric cancer cells in vivo and in vitro.
    Wu Q, Chen YQ, Chen ZM, Chen F, Su WJ.
    Acta Pharmacol Sin; 2002 Sep 01; 23(9):835-41. PubMed ID: 12230954
    [Abstract] [Full Text] [Related]

  • 16. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA.
    Cancer Chemother Pharmacol; 2009 Jun 01; 64(1):53-65. PubMed ID: 18931998
    [Abstract] [Full Text] [Related]

  • 17. Comparison of antitumor effect of recombinant L-asparaginase with wild type one in vitro and in vivo.
    Guo QL, Wu MS, Chen Z.
    Acta Pharmacol Sin; 2002 Oct 01; 23(10):946-51. PubMed ID: 12370101
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of a recombinant soluble betaglycan in human breast cancer xenograft.
    Bandyopadhyay A, López-Casillas F, Malik SN, Montiel JL, Mendoza V, Yang J, Sun LZ.
    Cancer Res; 2002 Aug 15; 62(16):4690-5. PubMed ID: 12183427
    [Abstract] [Full Text] [Related]

  • 19. Marked antitumor activity of a new potent acronycine derivative in orthotopic models of human solid tumors.
    Guilbaud N, Kraus-Berthier L, Meyer-Losic F, Malivet V, Chacun C, Jan M, Tillequin F, Michel S, Koch M, Pfeiffer B, Atassi G, Hickman J, Pierré A.
    Clin Cancer Res; 2001 Aug 15; 7(8):2573-80. PubMed ID: 11489841
    [Abstract] [Full Text] [Related]

  • 20. Anti-tumor effect of a novel soluble recombinant human endostatin: administered as a single agent or in combination with chemotherapy agents in mouse tumor models.
    Ren Z, Wang Y, Jiang W, Dai W, Jiang Y.
    PLoS One; 2014 Aug 15; 9(9):e107823. PubMed ID: 25229620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 540.